We recently compiled a list of the 10 Best Investments During A Recession. Cardinal Health, Inc. is one of the best ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's ...

Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...

Cardinal Health (CAH) traded higher in the premarket on Tuesday after the pharmaceutical distributor increased its adjusted ...

Drug distributor Cardinal Health raised its 2026 profit forecast on Tuesday, driven ​by robust demand for specialty medicines ...

The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman.

Get the live share price of Cardinal Health Inc (CAH), including intraday charts, historical performance, key financials, and ...

Choose Columbus Business First as a preferred news source to see more of our reporting on Google.

In a report released today, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Cardinal Health, with a price target of $250.00.

DUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First ...

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...